Cargando…

Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions

Detalles Bibliográficos
Autores principales: Hall, Peter, McCabe, Christopher, Hulme, Claire, Edlin, Richard, Dunn, Janet, Cameron, David, Stein, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980319/
http://dx.doi.org/10.1186/1745-6215-14-S1-O5
_version_ 1782479513179914240
author Hall, Peter
McCabe, Christopher
Hulme, Claire
Edlin, Richard
Dunn, Janet
Cameron, David
Stein, Rob
author_facet Hall, Peter
McCabe, Christopher
Hulme, Claire
Edlin, Richard
Dunn, Janet
Cameron, David
Stein, Rob
author_sort Hall, Peter
collection PubMed
description
format Online
Article
Text
id pubmed-3980319
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39803192014-04-24 Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions Hall, Peter McCabe, Christopher Hulme, Claire Edlin, Richard Dunn, Janet Cameron, David Stein, Rob Trials Oral Presentation BioMed Central 2013-11-29 /pmc/articles/PMC3980319/ http://dx.doi.org/10.1186/1745-6215-14-S1-O5 Text en Copyright © 2013 Hall et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Hall, Peter
McCabe, Christopher
Hulme, Claire
Edlin, Richard
Dunn, Janet
Cameron, David
Stein, Rob
Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title_full Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title_fullStr Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title_full_unstemmed Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title_short Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
title_sort efficient design of a phase iii trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980319/
http://dx.doi.org/10.1186/1745-6215-14-S1-O5
work_keys_str_mv AT hallpeter efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT mccabechristopher efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT hulmeclaire efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT edlinrichard efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT dunnjanet efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT camerondavid efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions
AT steinrob efficientdesignofaphaseiiitrialofcompetingtestsforpersonalisedcancertreatmentintheabsenceofgoldstandardoutcomedatachallengesandpotentialsolutions